Brazil IVD Market Analysis

 
   Single User - $3,500
   Site License (one location, 10 users) - $5,250
   Corporate License - $7,000



Loading...
Published Jun 16, 2017 | 67 Pages | Pub ID: KLI15386111

Brazil IVD Market Analysis

Visit Kalorama Information's 'In Vitro Diagnostics' curated page for complete industry coverage.

The Brazilian in vitro diagnostic (IVD) market is ripe for entry. The country has a growing middle class, stabilizing economy, increasing urban population, and a supportive government. The county is witnessing a major shift toward the private health industry, which supports growth of IVD technologies that are expensive or not typically covered at the public level. An increasing interest in molecular testing technologies, prenatal screening, and point-of-care (POC) glucose testing are driving market growth.

Brazil IVD Market Segmentation

Brazil IVD Market Analysis is designed to provide the reader with an overview of the Brazilian laboratory market and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators and controls of the following sub-segments:
  • Clinical Chemistry
  • Immunoassays
  • Microbiology and Molecular Testing
  • Point-of-Care Testing
Increasing incidence of non-communicable disease, a steady incidence of infectious diseases, an increasing disease risk with current lifestyle trends (higher obesity rate, lower activity rates), and other factors have contributed to the current and future Brazil IVD market outlook as outlined in the report:
  • Brazil IVD Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology/Molecular, POC, Histology, Other, Total)
  • Brazil IVD Sales by Market Segment, 2016 Market Distribution (%) (Clinical Chemistry, Immunoassays, Microbiology/Molecular, POC, Histology, Other)
  • Brazil - Clinical Chemistry Market, 2016-2021
  • Brazil - Immunoassay Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Immunoassay)
  • Brazil - Immunoassay Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
  • Brazil - Microbiology/Molecular Testing Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Microbiology/Molecular Testing)
  • Brazil Microbiology/Molecular Testing Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
  • POC Market Distribution, 2016-2021 (%) (POC Glucose, POC Infectious Disease, POC Other, Total POC)
  • Brazil POC Market Value by Segment, 2016 vs. 2021 (POC Glucose, POC Infectious Disease, Others)
  • Brazil - Histology Market, 2016-2021
Included in Brazil IVD Market Analysis are trends influencing the industry and country-level data including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences.

Company Profiles

The IVD market is highly competitive worldwide and Latin America is no exception. Brazil's IVD market is dominated by a handful of global competitors, which are profiled in the report:
  • Abbott Laboratories
  • Alere
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Danaher Corporation
  • Roche (F. Hoffman-La Roche, Ltd.)
  • Siemens Healthineers
  • Sysmex Corporation

Scope & Methodology

The information in Brazil IVD Market Analysis was gathered using both primary and secondary research methods including more than 25 interviews completed during the period of April 2017 and June 2017. These interviews were with government officials, medical device regulators, Brazilian-based distributors, health care providers and leading market participants. In some cases, the use of a third-party interpreter service was used to complete the interview. Secondary data included the use of government databases, company literature, medical journals and reports.
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.